Medicare Enrolled
Dr. Simon Starosta-Rubinstein, MD
Neurology · South Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Starosta-Rubinstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Starosta-Rubinstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Starosta-Rubinstein
Dr. Simon Starosta-Rubinstein is a neurology specialist in South Miami, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Starosta-Rubinstein performed 1,178 Medicare services across 746 unique beneficiaries.
Between the years covered by Open Payments, Dr. Starosta-Rubinstein received a total of $15,824 from 81 pharmaceutical and/or device companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Starosta-Rubinstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 28% volume in FL
$15,824 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 103820 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗1,178
Medicare services
Top 28% in FL for neurology
746
Unique beneficiaries
$133
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~74 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
656 | $99 | $562 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 126 | $216 | $1,021 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
97 | $358 | $1,914 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
51 | $29 | $155 |
| New patient office visit, complex (60-74 min) | 46 | $167 | $976 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
25 | $231 | $1,311 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
24 | $135 | $680 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
17 | $32 | $177 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
17 | $81 | $465 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
17 | $9 | $30 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
17 | $108 | $560 |
| Additional hour of neuropsychological test evaluation This code covers the evaluation of neuropsychological testing for each additional hour beyond the initial service. It represents the time spent analyzing and interpreting test results. |
17 | $81 | $433 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
17 | $28 | $155 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
14 | $150 | $1,037 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
13 | $98 | $517 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $77 | $397 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $153 | $788 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,824
Total received (2018-2024)
Avg $2,261/year across 7 years
Top 20% in FL for neurology
81
Companies
860
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,315 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$509 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,898
2023
$2,275
2022
$2,252
2021
$3,007
2020
$1,423
2019
$1,824
2018
$2,145
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$1,474
Neurocrine Biosciences, Inc.
$1,046
UCB, Inc.
$1,046
Lilly USA, LLC
$691
ACADIA Pharmaceuticals Inc
$640
Biogen, Inc.
$612
Amgen Inc.
$559
Mallinckrodt Hospital Products Inc.
$525
SK Life Science, Inc.
$481
ARGENX US, INC.
$447
Kyowa Kirin, Inc.
$411
Acorda Therapeutics, Inc
$397
Adamas Pharmaceuticals, Inc.
$392
Amneal Pharmaceuticals LLC
$365
ABBVIE INC.
$340
PFIZER INC.
$334
EMD Serono, Inc.
$318
Almatica Pharma LLC
$295
Allergan Inc.
$274
Supernus Pharmaceuticals, Inc.
$270
Lundbeck LLC
$253
Eisai Inc.
$237
Novartis Pharmaceuticals Corporation
$220
Otsuka America Pharmaceutical, Inc.
$201
Allergan, Inc.
$201
AbbVie Inc.
$191
GENZYME CORPORATION
$171
Sunovion Pharmaceuticals Inc.
$167
Biohaven Pharmaceuticals, Inc.
$165
E.R. Squibb & Sons, L.L.C.
$165
CSL Behring
$150
MDD US Operations, LLC
$148
Avanir Pharmaceuticals, Inc.
$148
MITSUBISHI TANABE PHARMA AMERICA, INC.
$145
Horizon Therapeutics plc
$138
Upsher-Smith Laboratories LLC
$135
AstraZeneca Pharmaceuticals LP
$129
Neurelis, Inc.
$120
Avion Pharmaceuticals
$116
Biohaven Pharmaceutical Holding Company Ltd.
$111
Mitsubishi Tanabe Pharma America, Inc.
$109
Celgene Corporation
$104
Alexion Pharmaceuticals, Inc.
$91
US WorldMeds, LLC
$85
EISAI INC.
$70
Abbott Laboratories
$68
BANNER LIFE SCIENCES, LLC
$66
Corium, LLC
$66
Takeda Pharmaceuticals U.S.A., Inc.
$61
Grifols USA, LLC
$53
TG Therapeutics, Inc.
$46
Assertio Therapeutics, Inc.
$46
Mallinckrodt LLC
$43
Scilex Pharmaceuticals Inc.
$42
Alfasigma USA, Inc.
$38
Janssen Pharmaceuticals, Inc
$37
Bayer HealthCare Pharmaceuticals Inc.
$36
Merz Pharmaceuticals, LLC
$35
CATALYST PHARMACEUTICALS, INC.
$35
ANI Pharmaceuticals, Inc.
$33
Akcea Therapeutics, Inc.
$33
ARBOR PHARMACEUTICALS, INC.
$32
Medtronic USA, Inc.
$32
TG THERAPEUTICS, INC.
$25
Impax Laboratories, Inc.
$24
AQUESTIVE THERAPEUTICS, INC.
$22
SCILEX PHARMACEUTICALS INC.
$22
Sobi, Inc
$22
LivaNova USA, Inc.
$22
Banner Life Sciences, LLC
$21
Philips Electronics North America Corporation
$20
Collegium Pharmaceutical, Inc.
$20
Boston Scientific Corporation
$19
Promius Pharma LLC
$19
InSightec,Inc
$18
Currax Pharmaceuticals LLC
$15
Aprecia Pharmaceuticals, LLC
$15
JAZZ PHARMACEUTICALS INC.
$14
Dynasplint Systems Inc.
$13
Egalet US Inc
$13
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 22.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · DUOPA · Dhivy · Dynasplint · EMGALITY · EPIDIOLEX · EVUSHELD · Exablate · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Solitaire · Spritam · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WATCHMAN · XTAMPZAER · Xadago · Xeomin · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1,343 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
253
Per 100K population
9.4
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Starosta-Rubinstein is a clinical cardiology specialist, with above-average Medicare volume (top 28% in FL), with low-engagement industry engagement in the top 20% of FL peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Starosta-Rubinstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Starosta-Rubinstein performed 656 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Starosta-Rubinstein receive payments from pharmaceutical companies?
Yes. Dr. Starosta-Rubinstein received a total of $15,824 from 81 companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Starosta-Rubinstein's costs compare to other neurologists in South Miami?
Dr. Starosta-Rubinstein's average Medicare payment per service is $133. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Starosta-Rubinstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in South Miami
Browse neurologists in South Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology